427 studies found for:
butyrylcholinesterase
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient Subjects
|
||||
| 2 | Completed |
A Study of Plasma-Derived Human Butyrylcholinesterase Administered Intramuscularly
|
||||
| 3 | Completed |
Pharmacokinetic (PK) and Safety Study of Plasma-Derived Human Butyrylcholinesterase Administered Intravenously
|
||||
| 4 | Completed |
Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults
|
||||
| 5 | Not yet recruiting |
Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson's Disease
|
||||
| 6 | Completed |
Estimation of Functional Liver Reserve Using Cholinesterases
|
||||
| 7 | Completed |
Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
|
||||
| 8 | Completed |
Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease
|
||||
| 9 | Recruiting |
Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors
|
||||
| 10 | Not yet recruiting |
Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI
|
||||
| 11 | Completed |
Use of Donepezil for Treatment of Cocaine Dependence
|
||||
| 12 | Completed |
To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.
|
||||
| 13 | Completed |
Effects of Donepezil on Deficits Associated With Age-Related Decrease of Growth Hormone
|
||||
| 14 | Completed |
Efficacy of Rivastigmine in Patients With Down Syndrome
|
||||
| 15 | Completed |
Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia
|
||||
| 16 | Completed |
Treatment of Tardive Dyskinesia With Galantamine
|
||||
| 17 | Unknown † |
Dementia Early Recognition and Response in Primary Care
|
||||
| 18 | Terminated |
Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice
|
||||
| 19 | Active, not recruiting |
Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice
|
||||
| 20 | Recruiting |
The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy
|
† Indicates status has not been verified in more than two years
